arrow_back Back to App

Access to Experimental Drugs: Expanding Right to Try

This act aims to broaden access to experimental drugs for patients with serious illnesses. It allows the use of substances that have completed initial safety trials, even if they are controlled substances. This provides patients with a potential treatment option when other avenues have been exhausted.
Key points
Expands patients' right to try experimental drugs, including certain controlled substances.
Grants access to drugs that have completed Phase I clinical trials and show promising results.
Offers hope to seriously ill patients for access to innovative therapies not yet fully approved.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_4575
Sponsor: Sen. Booker, Cory A. [D-NJ]
Process start date: 2022-07-20